ATE368050T1 - Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben - Google Patents
Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselbenInfo
- Publication number
- ATE368050T1 ATE368050T1 AT98960246T AT98960246T ATE368050T1 AT E368050 T1 ATE368050 T1 AT E368050T1 AT 98960246 T AT98960246 T AT 98960246T AT 98960246 T AT98960246 T AT 98960246T AT E368050 T1 ATE368050 T1 AT E368050T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- same
- steroid derivatives
- androgenic steroid
- androgenic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0077—Ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/979,369 US5952319A (en) | 1997-11-26 | 1997-11-26 | Androgenic steroid compounds and a method of making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE368050T1 true ATE368050T1 (de) | 2007-08-15 |
Family
ID=25526867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98960246T ATE368050T1 (de) | 1997-11-26 | 1998-11-23 | Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben |
Country Status (11)
Country | Link |
---|---|
US (4) | US5952319A (de) |
EP (1) | EP1042352B1 (de) |
JP (1) | JP2001524487A (de) |
KR (1) | KR100577129B1 (de) |
CN (1) | CN1257181C (de) |
AT (1) | ATE368050T1 (de) |
AU (1) | AU750663B2 (de) |
CA (1) | CA2311448A1 (de) |
DE (1) | DE69838146D1 (de) |
NO (1) | NO317879B1 (de) |
WO (1) | WO1999026962A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
US5952319A (en) * | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
ATE301129T1 (de) * | 1999-05-04 | 2005-08-15 | Strakan Int Ltd | Androgen glykoside und die androgenische aktivität davon |
US6740645B1 (en) | 1999-09-03 | 2004-05-25 | Research Triangle Institute | 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
ATE334682T1 (de) * | 2000-03-31 | 2006-08-15 | Us Gov Health & Human Serv | Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung |
WO2001091744A1 (en) * | 2000-05-26 | 2001-12-06 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
GB0025221D0 (en) * | 2000-10-14 | 2000-11-29 | Astrazeneca Ab | New process |
WO2002048169A1 (en) * | 2000-12-15 | 2002-06-20 | Akzo Nobel N.V. | 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
DE10104327A1 (de) | 2001-01-24 | 2002-07-25 | Schering Ag | 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate |
WO2003026568A2 (en) * | 2001-09-21 | 2003-04-03 | Merck & Co., Inc. | Androstanes as androgen receptor modulators |
DE10234525A1 (de) * | 2002-07-25 | 2004-02-05 | Schering Ag | Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung |
US20040010138A1 (en) * | 2002-03-21 | 2004-01-15 | Schering Ag | Process for the production of 7alpha-methyl steroids |
RS51855B (sr) | 2002-07-24 | 2012-02-29 | Bayer Schering Pharma Aktiengesellschaft | Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida |
DE10233723A1 (de) * | 2002-07-24 | 2004-02-12 | Schering Ag | Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene |
ATE382355T1 (de) * | 2002-07-25 | 2008-01-15 | Bayer Schering Pharma Ag | Zusammensetzung, enthaltend ein androgenes 11-b- halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung |
CA2496867A1 (en) | 2002-08-28 | 2004-03-11 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment methods |
US8445469B2 (en) * | 2004-12-30 | 2013-05-21 | Bayer Intellectual Property Gmbh | 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter |
JP5227593B2 (ja) * | 2005-02-04 | 2013-07-03 | アメリカ合衆国 | ナンドロロン17β−カーボネート |
US11072632B2 (en) * | 2011-03-25 | 2021-07-27 | UNIVERSITé LAVAL | Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD10 |
EP4164743A2 (de) * | 2020-06-11 | 2023-04-19 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Darstellung monomerer und oligomerer verbindungen als kontrazeptiva und therapien sowie verfahren zur herstellung und verwendung davon |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB912036A (en) * | 1960-06-23 | 1962-12-05 | British Drug Houses Ltd | 11-methylene-5ª--steroids |
GB912037A (en) * | 1960-06-27 | 1962-12-05 | British Drug Houses Ltd | 11-methylene steroids |
GB912038A (en) * | 1960-06-30 | 1962-12-05 | British Drug Houses Ltd | 11ª--methyl-5ª--steroids |
US3846456A (en) * | 1965-04-07 | 1974-11-05 | Upjohn Co | Organic compounds |
US3325520A (en) * | 1965-12-08 | 1967-06-13 | Searle & Co | (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding |
US3652606A (en) * | 1970-08-07 | 1972-03-28 | Searle & Co | 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof |
US3927046A (en) * | 1972-12-09 | 1975-12-16 | Akzona Inc | Novel 11,11-alkylidene steroids |
US4412993A (en) * | 1980-01-25 | 1983-11-01 | The Upjohn Company | Method of treating pseudopregnancy, galactorrhea and mastitis in mammals |
DE3909770A1 (de) * | 1989-03-21 | 1990-09-27 | Schering Ag | Verfahren zur herstellung von 3-desoxy-4-en-steroiden |
AU3257993A (en) * | 1991-12-22 | 1993-07-28 | Schering Aktiengesellschaft | 3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs |
US5733565A (en) * | 1996-02-23 | 1998-03-31 | The Population Council, Center For Biomedical Research | Male contraceptive implant |
US5952319A (en) * | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
ATE334682T1 (de) | 2000-03-31 | 2006-08-15 | Us Gov Health & Human Serv | Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung |
US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
-
1997
- 1997-11-26 US US08/979,369 patent/US5952319A/en not_active Expired - Fee Related
-
1998
- 1998-11-23 WO PCT/US1998/024527 patent/WO1999026962A1/en active IP Right Grant
- 1998-11-23 KR KR1020007005690A patent/KR100577129B1/ko not_active IP Right Cessation
- 1998-11-23 CN CNB988127962A patent/CN1257181C/zh not_active Expired - Fee Related
- 1998-11-23 AU AU15891/99A patent/AU750663B2/en not_active Ceased
- 1998-11-23 CA CA002311448A patent/CA2311448A1/en not_active Abandoned
- 1998-11-23 JP JP2000522119A patent/JP2001524487A/ja active Pending
- 1998-11-23 AT AT98960246T patent/ATE368050T1/de not_active IP Right Cessation
- 1998-11-23 EP EP98960246A patent/EP1042352B1/de not_active Expired - Lifetime
- 1998-11-23 DE DE69838146T patent/DE69838146D1/de not_active Expired - Lifetime
-
1999
- 1999-06-09 US US09/328,436 patent/US6369047B2/en not_active Expired - Fee Related
-
2000
- 2000-05-25 NO NO20002676A patent/NO317879B1/no unknown
-
2002
- 2002-01-22 US US10/051,172 patent/US6670352B2/en not_active Expired - Fee Related
-
2003
- 2003-11-04 US US10/699,885 patent/US6864248B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20040097477A1 (en) | 2004-05-20 |
NO20002676L (no) | 2000-05-25 |
US5952319A (en) | 1999-09-14 |
KR20010032449A (ko) | 2001-04-25 |
AU1589199A (en) | 1999-06-15 |
US6864248B2 (en) | 2005-03-08 |
EP1042352A1 (de) | 2000-10-11 |
EP1042352A4 (de) | 2004-12-22 |
US20020002156A1 (en) | 2002-01-03 |
US20020103177A1 (en) | 2002-08-01 |
KR100577129B1 (ko) | 2006-05-09 |
US6670352B2 (en) | 2003-12-30 |
NO317879B1 (no) | 2004-12-27 |
NO20002676D0 (no) | 2000-05-25 |
US6369047B2 (en) | 2002-04-09 |
EP1042352B1 (de) | 2007-07-25 |
DE69838146D1 (de) | 2007-09-06 |
CA2311448A1 (en) | 1999-06-03 |
JP2001524487A (ja) | 2001-12-04 |
CN1257181C (zh) | 2006-05-24 |
CN1283200A (zh) | 2001-02-07 |
WO1999026962A1 (en) | 1999-06-03 |
AU750663B2 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE368050T1 (de) | Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben | |
ATE250077T1 (de) | Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung | |
ATE239751T1 (de) | 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung | |
ATE266030T1 (de) | 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen | |
ATE325788T1 (de) | Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung | |
ATE197150T1 (de) | Verfahren zur herstellung von dihydroxypyrimidin- derivaten | |
DE69808771D1 (de) | Ein verfahren zur herstellung von tetraaza makrocyclen | |
ATE298747T1 (de) | Verfahren zur herstellung von 5- hydroxybenzo(b)thiophen-3-carbonsäure | |
BR9713176A (pt) | Benzotiofenos amorfos,métodos de preparação e métodos de uso | |
DE69920708D1 (de) | Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion | |
MY115727A (en) | Substituted aminoquinazolinone (thione) derivatives or salts thereof intermediates thereof, and pest controllers and a method for using the same | |
ATE385232T1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
ATE229006T1 (de) | Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte | |
ATE324366T1 (de) | Verfahren zur herstellung von 3-pyrrolin-2- carbonsäure-derivaten | |
DE69902120D1 (de) | Verfahren zur Herstellung von Acetylenderivaten | |
ATE244706T1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
ATE234288T1 (de) | Verfahren zur herstellung eines buthylthuio- isochinolinderivates und zwischenprodukte dafür | |
ATE186737T1 (de) | Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden | |
DE69839732D1 (de) | Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion | |
ATE238779T1 (de) | Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung | |
ATE215561T1 (de) | Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung | |
ATE195115T1 (de) | Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten | |
ATE501158T1 (de) | Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
DE69616801D1 (de) | Eintopfverfahren zur herstellung von 2-oxazolidinonderivate | |
DE59907804D1 (de) | Verbessertes verfahren zur herstellung von pharmazeutisch wertvollen norbenzomorphanderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |